Alberto Benito Boillos-rekin lankidetzan egindako argitalpenak (8)

2013

  1. Safety and liver transduction efficacy of raav5-cohpbgd in nonhuman primates: A potential therapy for acute intermittent porphyria

    Human Gene Therapy, Vol. 24, Núm. 12, pp. 1007-1017

2008

  1. Asociación de marcadores inflamatorios y aterosclerosis subclínica en relación con la edad en sujetos sin enfermedad cardiovascular

    Medicina Clinica, Vol. 131, Núm. 10, pp. 361-365

2005

  1. Monocyte cyclooxygenase-2 overactivity: A new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

    European Heart Journal, Vol. 26, Núm. 2, pp. 153-158

2004

  1. Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease

    Stroke, Vol. 35, Núm. 5, pp. 1085-1089

  2. Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease

    Haematologica, Vol. 89, Núm. 10, pp. 1226-1231

2003

  1. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects

    Cerebrovascular Diseases, Vol. 16, Núm. 4, pp. 356-362

2002

  1. Easy venous superdrainage in DIEP flap breast reconstruction through the intercostal branch

    Journal of Reconstructive Microsurgery, Vol. 18, Núm. 7, pp. 595-598

1998

  1. Magnetic resonance imaging in a patient with a dual-chamber pacemaker

    Acta Cardiologica, Vol. 53, Núm. 1, pp. 33-35